18-Jun-2026
Globe Newswire (Fri, 19-Jun 9:28 AM ET)
Business Wire (Thu, 18-Jun 4:29 PM ET)
Business Wire (Thu, 18-Jun 4:08 PM ET)
Are FTHM, ALOT, SLP, ROKU Obtaining Fair Deals for their Shareholders?
PRNewswire (Thu, 18-Jun 11:27 AM ET)
Simulations Plus (SLP) Gets a Buy from Craig-Hallum
TipRanks (Thu, 18-Jun 5:25 AM ET)
Simulations Plus to Be Acquired by Altaris Affiliate
TipRanks (Wed, 17-Jun 5:44 PM ET)
Globe Newswire (Wed, 17-Jun 12:04 PM ET)
TipRanks (Wed, 17-Jun 6:40 AM ET)
Simulations Plus (SLP) was downgraded to a Hold Rating at William Blair
TipRanks (Wed, 17-Jun 5:27 AM ET)
Globe Newswire (Tue, 16-Jun 9:04 PM ET)
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Simulations Plus trades on the NASDAQ stock market under the symbol SLP.
As of June 18, 2026, SLP stock price declined to $18.24 with 972,964 million shares trading.
SLP has a beta of 2.43, meaning it tends to be more sensitive to market movements. SLP has a correlation of 0.15 to the broad based SPY ETF.
SLP has a market cap of $368.55 million. This is considered a Small Cap stock.
Last quarter Simulations Plus reported $24 million in Revenue and $.35 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.06.
In the last 3 years, SLP traded as high as $52.69 and as low as $11.09.
The top ETF exchange traded funds that SLP belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.
SLP has underperformed the market in the last year with a return of +0.9%, while SPY returned +26.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SLP shares. However, SLP has outperformed the market in the last 3 month and 2 week periods, returning +56.8% and +9.5%, while SPY returned +13.5% and -1.1%, respectively. This indicates SLP has been having a stronger performance recently.
SLP support price is $17.52 and resistance is $18.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLP shares will trade within this expected range on the day.